Jams Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 3.00 Cr
- Company Age 4 Year, 26 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 20.29 Cr
- Revenue Growth 78.54%
- Profit Growth 7.04%
- Ebitda 27.14%
- Net Worth 7.43%
- Total Assets 59.85%
About Jams Lifesciences
Jams Lifesciences Private Limited (JLPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 January 2021 (Four years 26 days old ). Its registered office is in Dehradun, Uttarakhand, India.
The Corporate was formerly known as Jams Industries Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹20.29 Cr.
Anuj Parashar, Subhash Sharma, and Akshita Sharma serve as directors at the Company.
Company Details
-
Location
Dehradun, Uttarakhand, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24290UR2021PTC011985
-
Company No.
011985
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Jan 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Uttarakhand
Industry
Who are the key members and board of directors at Jams Lifesciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anuj Parashar
|
Director | 21-Jan-2021 | Current |
|
Subhash Sharma
|
Director | 21-Jan-2021 | Current |
|
Akshita Sharma
|
Director | 30-Aug-2023 | Current |
Financial Performance of Jams Lifesciences.
Jams Lifesciences Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 78.54% increase. The company also saw a slight improvement in profitability, with a 7.04% increase in profit. The company's net worth moved up by a moderate rise of 7.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jams Lifesciences?
Unlock access to Jams Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹20.29 Cr
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 20.29 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Sep 2021 | Indian Bank | ₹20.29 Cr | Open |
How Many Employees Work at Jams Lifesciences?
Jams Lifesciences has a workforce of 44 employees as of Feb 07, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jams Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jams Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.